Medtech, a company specializing in the design, development and marketing of innovative surgical robots, announced the sale of three ROSA surgical robots in Asia, marking an increased adoption in the Asian market.
ROSA is an integrated multi-application console that works as a reliable and accurate surgical assistant. The robotic device was designed to increase the safety and reliability of various neurological procedures without compromising established surgical protocols.
Bertin Nahum, CEO and Founder of Medtech said: “The sale of three ROSA surgical robots in the past month continues to demonstrate the growing demand for precision surgical robotics both in the region and globally. Our consistent sales performance in the region highlights the success of Medtech’s commercial activities in this promising Asian market.”
Two of the three ROSA systems were sold in China, a key driver in Asia and one of Medtech’s target markets for growth. With the sale of these two units, Medtech now has seven ROSA robots in China.
The third ROSA unit was sold in India, the second most populated country in the world with 1.27 billion inhabitants. The robot was purchased by the All India Institute of Medical Sciences (AIIMS) hospital in New Delhi. AIIMS hospital is a leading national institute for medical education and its center for neurosurgery treats more than 3,000 neurosurgery patients and 1,500 trauma patients each year.
Medtech
www.medtech.fr/en/rosa1
